SlideShare a Scribd company logo
Drugs acting on Renin Angiotensin System
1. Angiotensin converting Enzyme Inhibitors (ACEI)
2. Angiotensin-II Receptor Blockers (ARBS)
1.ACE Inhibitors
Based on the Zn2+ binding groups
Sulphydral containing inhibitors: Captopril
Dicarboxylate containing inhibitors:
Enalapril, Lisinopril, Ramipril, Quinapril, Perindropril
Phosphate containing inhibitors: Fosinpril
Captopril & Lisinopril are non prodrugs
Remaining drugs are prodrugs
Captopril
-SH group enhance binding to Zn2+
In the ACE
The carboxylate ion (COO-) attract the
cationic site of the ACE by arginine residue, b/s of above
attachments, the carbonyl group becomes polarized
and more susceptible to hydrolysis instead of
angitensin-I
2-CH3 is important for action.
Substitution of other amino acid with proline
decrease the activity.
SAR
The N-ring must contain carboxylic acid
The N-ring should be large hydrophobic rings b/s it
increase the potency by altering pharmacokinetic
parameters
The A, B, C groups can serve as Zn2+ binding sites
The thiol group shows superior binding to Zn2+ among
the carboxylate and phosphate.
Estrification of carboxylate (B) and phosphate (C)
produces orally active products
 The X should be –CH3
In carboxylate derivatives X should be n- butylamine
The n usually 2 for activity
ACEI
Angiotensinogen
Angiotensin I
Angiotensin II
Renin
ACE
X
MOA OF ACEI
Aldoserone
Na reabsorption
Blood volume
Cardiac output
BP
ACEI
Aldoserone
Na reabsorption
Blood volume
Cardiac output
BP
Therapeutic Uses
Anti-hypertensive
Prevent or reverse LVH
Protect against sudden death and second
myocardial infarction after acute MI
Improve survival and hemodynamics in patients
with congestive heart failure
Protect against progression of diabetic
nephropathy
Adverse Effects
Hypotension
Renal Insufficiency (if bilateral renal artery
stenosis)
Hyperkalemia – special group of patients (Na
restricted, on K-sparing diuretic, COX inhibitors)
Cough (20 %)
Angioedema
With captopril especially: neutropenia, nephrotic
syndrome, skin rash, taste disturbances (SH
group- related).
2. Angiotensin-II Receptor Blockers (ARBS)
Losartan
Valsartan
Telmisartan
Candesartan
Olmesartan
MOA
Angiotensin II receptor blockers (ARBs) act
differently from ACE inhibitors.
These drugs block the angiotensin-II binding to its
receptor,
Aldoserone production
Na reabsorption
Blood volume
Cardiac output
BP
Angiotensin II receptor
blockers can be used to
treat
coronary artery disease,
heart failure,
high blood pressure,
kidney disease.
Side effects
Chest pain
Back pain
Peripheral edema
Facial edema
Dry cough (less common)
Synthesis of Captopril

More Related Content

Similar to newmicrosoftofficepowerpointpresentation-160518101853 (1).pdf

Drugs used in Cardiac Failure
Drugs used in Cardiac FailureDrugs used in Cardiac Failure
Drugs used in Cardiac Failure
Eneutron
 
Antihypertensive
AntihypertensiveAntihypertensive
Antihypertensive
Owuor Odongo
 
Lecture 9. Cardiotonic and antiarrhythmic drugs.pdf
Lecture 9. Cardiotonic and antiarrhythmic drugs.pdfLecture 9. Cardiotonic and antiarrhythmic drugs.pdf
Lecture 9. Cardiotonic and antiarrhythmic drugs.pdf
alishmaart
 
Antihypertensive agent
Antihypertensive agentAntihypertensive agent
Antihypertensive agent
amol dighe
 
Anti-Hypertensive Drugs Medicinal Chemistry
Anti-Hypertensive Drugs Medicinal ChemistryAnti-Hypertensive Drugs Medicinal Chemistry
Anti-Hypertensive Drugs Medicinal Chemistry
HarshVardhanRao4
 
Diuretics, cardiovascular drugs, antiplatelets n anticoagulant.
Diuretics, cardiovascular drugs, antiplatelets n anticoagulant.Diuretics, cardiovascular drugs, antiplatelets n anticoagulant.
Diuretics, cardiovascular drugs, antiplatelets n anticoagulant.
soumyakanta
 
Antianginal drugs.pptx
Antianginal drugs.pptxAntianginal drugs.pptx
Antianginal drugs.pptx
Awais irshad
 
Duane phchem ppt
Duane phchem pptDuane phchem ppt
Duane phchem ppt
Duane Goodman
 
Antihypertensive
AntihypertensiveAntihypertensive
Antihypertensive
MdNazmulIslamTanmoy
 
Pharmacology notes
Pharmacology notesPharmacology notes
Pharmacology notes
Mohammad Alauddin
 
antihypertension drugs.ppt
antihypertension drugs.pptantihypertension drugs.ppt
antihypertension drugs.ppt
TigerSori
 
Anti hypertensive drugs
Anti hypertensive drugsAnti hypertensive drugs
Anti hypertensive drugs
HimanshuJoshi255
 
ANTIHYPERTENSIVE AGENTS
ANTIHYPERTENSIVE AGENTSANTIHYPERTENSIVE AGENTS
ANTIHYPERTENSIVE AGENTS
Aswinisasidharan
 
Drugs affecting cardiovascular system
Drugs affecting cardiovascular systemDrugs affecting cardiovascular system
Drugs affecting cardiovascular systemDina Ghoraba
 
ANTI HYPERTENSIVE DRUGS
ANTI HYPERTENSIVE DRUGS ANTI HYPERTENSIVE DRUGS
ANTI HYPERTENSIVE DRUGS
Leela Munnangi
 
SYMPATHOMIMTIC AND SYMPATHOLYTICS DRUGS.pptx
SYMPATHOMIMTIC AND SYMPATHOLYTICS DRUGS.pptxSYMPATHOMIMTIC AND SYMPATHOLYTICS DRUGS.pptx
SYMPATHOMIMTIC AND SYMPATHOLYTICS DRUGS.pptx
MsSapnaSapna
 
2nd unit anti-hypertensive agents ppt
2nd unit anti-hypertensive agents ppt2nd unit anti-hypertensive agents ppt
2nd unit anti-hypertensive agents ppt
NikithaGopalpet
 
Antihypertensive agents
Antihypertensive agentsAntihypertensive agents
Antihypertensive agents
K.suresh Kumar
 
anti hypertensive pharmacology.pptx
anti hypertensive pharmacology.pptxanti hypertensive pharmacology.pptx
anti hypertensive pharmacology.pptx
CharlesSsekawu
 
Antihypertensive Drugs Farmacos antihipertensivos
Antihypertensive Drugs Farmacos antihipertensivosAntihypertensive Drugs Farmacos antihipertensivos
Antihypertensive Drugs Farmacos antihipertensivos
ssuser98e2cf1
 

Similar to newmicrosoftofficepowerpointpresentation-160518101853 (1).pdf (20)

Drugs used in Cardiac Failure
Drugs used in Cardiac FailureDrugs used in Cardiac Failure
Drugs used in Cardiac Failure
 
Antihypertensive
AntihypertensiveAntihypertensive
Antihypertensive
 
Lecture 9. Cardiotonic and antiarrhythmic drugs.pdf
Lecture 9. Cardiotonic and antiarrhythmic drugs.pdfLecture 9. Cardiotonic and antiarrhythmic drugs.pdf
Lecture 9. Cardiotonic and antiarrhythmic drugs.pdf
 
Antihypertensive agent
Antihypertensive agentAntihypertensive agent
Antihypertensive agent
 
Anti-Hypertensive Drugs Medicinal Chemistry
Anti-Hypertensive Drugs Medicinal ChemistryAnti-Hypertensive Drugs Medicinal Chemistry
Anti-Hypertensive Drugs Medicinal Chemistry
 
Diuretics, cardiovascular drugs, antiplatelets n anticoagulant.
Diuretics, cardiovascular drugs, antiplatelets n anticoagulant.Diuretics, cardiovascular drugs, antiplatelets n anticoagulant.
Diuretics, cardiovascular drugs, antiplatelets n anticoagulant.
 
Antianginal drugs.pptx
Antianginal drugs.pptxAntianginal drugs.pptx
Antianginal drugs.pptx
 
Duane phchem ppt
Duane phchem pptDuane phchem ppt
Duane phchem ppt
 
Antihypertensive
AntihypertensiveAntihypertensive
Antihypertensive
 
Pharmacology notes
Pharmacology notesPharmacology notes
Pharmacology notes
 
antihypertension drugs.ppt
antihypertension drugs.pptantihypertension drugs.ppt
antihypertension drugs.ppt
 
Anti hypertensive drugs
Anti hypertensive drugsAnti hypertensive drugs
Anti hypertensive drugs
 
ANTIHYPERTENSIVE AGENTS
ANTIHYPERTENSIVE AGENTSANTIHYPERTENSIVE AGENTS
ANTIHYPERTENSIVE AGENTS
 
Drugs affecting cardiovascular system
Drugs affecting cardiovascular systemDrugs affecting cardiovascular system
Drugs affecting cardiovascular system
 
ANTI HYPERTENSIVE DRUGS
ANTI HYPERTENSIVE DRUGS ANTI HYPERTENSIVE DRUGS
ANTI HYPERTENSIVE DRUGS
 
SYMPATHOMIMTIC AND SYMPATHOLYTICS DRUGS.pptx
SYMPATHOMIMTIC AND SYMPATHOLYTICS DRUGS.pptxSYMPATHOMIMTIC AND SYMPATHOLYTICS DRUGS.pptx
SYMPATHOMIMTIC AND SYMPATHOLYTICS DRUGS.pptx
 
2nd unit anti-hypertensive agents ppt
2nd unit anti-hypertensive agents ppt2nd unit anti-hypertensive agents ppt
2nd unit anti-hypertensive agents ppt
 
Antihypertensive agents
Antihypertensive agentsAntihypertensive agents
Antihypertensive agents
 
anti hypertensive pharmacology.pptx
anti hypertensive pharmacology.pptxanti hypertensive pharmacology.pptx
anti hypertensive pharmacology.pptx
 
Antihypertensive Drugs Farmacos antihipertensivos
Antihypertensive Drugs Farmacos antihipertensivosAntihypertensive Drugs Farmacos antihipertensivos
Antihypertensive Drugs Farmacos antihipertensivos
 

Recently uploaded

"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Marketing internship report file for MBA
Marketing internship report file for MBAMarketing internship report file for MBA
Marketing internship report file for MBA
gb193092
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
kimdan468
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
chanes7
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 

Recently uploaded (20)

"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Marketing internship report file for MBA
Marketing internship report file for MBAMarketing internship report file for MBA
Marketing internship report file for MBA
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBCSTRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
STRAND 3 HYGIENIC PRACTICES.pptx GRADE 7 CBC
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Digital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion DesignsDigital Artifact 2 - Investigating Pavilion Designs
Digital Artifact 2 - Investigating Pavilion Designs
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 

newmicrosoftofficepowerpointpresentation-160518101853 (1).pdf

  • 1. Drugs acting on Renin Angiotensin System 1. Angiotensin converting Enzyme Inhibitors (ACEI) 2. Angiotensin-II Receptor Blockers (ARBS) 1.ACE Inhibitors Based on the Zn2+ binding groups Sulphydral containing inhibitors: Captopril Dicarboxylate containing inhibitors: Enalapril, Lisinopril, Ramipril, Quinapril, Perindropril Phosphate containing inhibitors: Fosinpril Captopril & Lisinopril are non prodrugs Remaining drugs are prodrugs
  • 2. Captopril -SH group enhance binding to Zn2+ In the ACE The carboxylate ion (COO-) attract the cationic site of the ACE by arginine residue, b/s of above attachments, the carbonyl group becomes polarized and more susceptible to hydrolysis instead of angitensin-I 2-CH3 is important for action. Substitution of other amino acid with proline decrease the activity.
  • 3. SAR The N-ring must contain carboxylic acid The N-ring should be large hydrophobic rings b/s it increase the potency by altering pharmacokinetic parameters
  • 4. The A, B, C groups can serve as Zn2+ binding sites The thiol group shows superior binding to Zn2+ among the carboxylate and phosphate. Estrification of carboxylate (B) and phosphate (C) produces orally active products  The X should be –CH3 In carboxylate derivatives X should be n- butylamine The n usually 2 for activity
  • 6. Angiotensinogen Angiotensin I Angiotensin II Renin ACE X MOA OF ACEI Aldoserone Na reabsorption Blood volume Cardiac output BP ACEI Aldoserone Na reabsorption Blood volume Cardiac output BP
  • 7. Therapeutic Uses Anti-hypertensive Prevent or reverse LVH Protect against sudden death and second myocardial infarction after acute MI Improve survival and hemodynamics in patients with congestive heart failure Protect against progression of diabetic nephropathy
  • 8. Adverse Effects Hypotension Renal Insufficiency (if bilateral renal artery stenosis) Hyperkalemia – special group of patients (Na restricted, on K-sparing diuretic, COX inhibitors) Cough (20 %) Angioedema With captopril especially: neutropenia, nephrotic syndrome, skin rash, taste disturbances (SH group- related).
  • 9. 2. Angiotensin-II Receptor Blockers (ARBS) Losartan Valsartan Telmisartan Candesartan Olmesartan
  • 10. MOA Angiotensin II receptor blockers (ARBs) act differently from ACE inhibitors. These drugs block the angiotensin-II binding to its receptor, Aldoserone production Na reabsorption Blood volume Cardiac output BP
  • 11. Angiotensin II receptor blockers can be used to treat coronary artery disease, heart failure, high blood pressure, kidney disease. Side effects Chest pain Back pain Peripheral edema Facial edema Dry cough (less common)